Financial Performance - GAAP net loss for Q4 2025 was $10.5 million, or $1.57 per share, compared to a net loss of $13.9 million, or $2.36 per share in Q4 2024[5] - Full year 2025 GAAP net loss was $50.2 million, or $8.19 per share, compared to a net loss of $63.2 million, or $10.74 per share in 2024[5] - Non-GAAP adjusted net loss for Q4 2025 was $11.1 million, or $1.65 per share, compared to $14.4 million, or $2.43 per share in Q4 2024[5] Operating Expenses - Total operating expenses for Q4 2025 were $9.3 million, a decrease of 38% compared to $15.0 million in Q4 2024[5] - Full year 2025 total operating expenses were $50.0 million, down 25% from $66.6 million in 2024[5] - Research and development expenses for Q4 2025 were $7.1 million, a 16% decrease from $8.5 million in Q4 2024[5] - Sales and marketing expenses for Q4 2025 were $0.4 million, a decrease of 56% from $1.0 million in Q4 2024[5] - General and administrative expenses for Q4 2025 were $2.6 million, down 53% from $5.5 million in Q4 2024[5] Cash and Investments - Cash and investments as of December 31, 2025, totaled $9.8 million, with a cash burn rate of $45.1 million for the full year 2025[5] - The company expects a cash burn of approximately $19 million for the full year 2026[4] - Cash and cash equivalents decreased from $9,737 million in 2024 to $2,569 million in 2025, a decline of approximately 73.6%[19] - Short-term investments decreased from $39,360 million in 2024 to $7,223 million in 2025, a reduction of about 81.7%[19] Assets and Liabilities - Total current assets decreased from $51,698 million in 2024 to $11,584 million in 2025, a decline of approximately 77.6%[19] - Total assets decreased from $67,719 million in 2024 to $19,581 million in 2025, representing a reduction of about 72.6%[19] - Total current liabilities decreased from $7,667 million in 2024 to $3,904 million in 2025, a decrease of approximately 49.1%[19] - Total liabilities decreased from $21,021 million in 2024 to $9,740 million in 2025, a decline of about 53.7%[19] - Stockholders' equity decreased from $46,698 million in 2024 to $9,841 million in 2025, a reduction of approximately 78.9%[19] - Accumulated deficit increased from $(195,935) million in 2024 to $(246,117) million in 2025, indicating a worsening of approximately 25.6%[19] - Additional paid-in capital increased from $242,566 million in 2024 to $255,937 million in 2025, an increase of about 5.5%[19] - Lease liabilities, net of current portion decreased from $12,567 million in 2024 to $5,836 million in 2025, a decrease of approximately 53.6%[19]
Vicarious Surgical (RBOT) - 2025 Q4 - Annual Results